TherapeuticsMD, Inc.TXMDNASDAQ
LOADING
|||
Switch Symbol:
Net Income Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-72.41%
↓ 7668% below average
Average (39q)
-0.93%
Historical baseline
Range
High:256.35%
Low:-359.13%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -72.41% |
| Q2 2025 | 184.38% |
| Q1 2025 | -359.13% |
| Q4 2024 | 141.38% |
| Q3 2024 | 44.13% |
| Q2 2024 | -48.50% |
| Q1 2024 | 16.87% |
| Q4 2023 | 73.86% |
| Q3 2023 | -39.93% |
| Q2 2023 | 33.00% |
| Q1 2023 | 89.15% |
| Q4 2022 | -14.69% |
| Q3 2022 | -125.80% |
| Q2 2022 | 256.35% |
| Q1 2022 | -67.16% |
| Q4 2021 | 9.41% |
| Q3 2021 | -11.18% |
| Q2 2021 | -8.30% |
| Q1 2021 | 6.42% |
| Q4 2020 | -29.05% |
| Q3 2020 | 37.26% |
| Q2 2020 | 8.57% |
| Q1 2020 | -15.00% |
| Q4 2019 | -54.65% |
| Q3 2019 | 42.13% |
| Q2 2019 | -39.82% |
| Q1 2019 | -0.29% |
| Q4 2018 | -10.63% |
| Q3 2018 | -7.18% |
| Q2 2018 | -36.13% |
| Q1 2018 | -13.88% |
| Q4 2017 | -46.12% |
| Q3 2017 | 25.47% |
| Q2 2017 | 6.99% |
| Q1 2017 | 7.36% |
| Q4 2016 | 8.71% |
| Q3 2016 | -18.59% |
| Q2 2016 | -0.79% |
| Q1 2016 | -19.71% |
| Q4 2015 | 10.22% |